Breast cancer (BC) patients with oestrogen receptor positivity (ER+) are treated in addition to surgery, chemotherapy, and/or radiation therapy with hormone therapy (Maughan et al., 2010; (McDonnell and Wardell 2010; NCI 2012). Here, ESR1 is linked to breast carcinoma.